Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Ribaudo Stephen PhilipEVP, Chief Operating Officer | Grant or award | A | — 8,925 sh | Sep 1, 2026 |
| 9 | Person JulieChief People Officer | Grant or award | A | — 212.4K sh | Sep 1, 2026 traded Sep 1, 2026 |
| 9 | Vollmer SonyaChief Human Resources Officer | Tax withholding | F | $13K 441 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 9 | schiller ThomasDirector, Strategic Advisor | Option exercise | M | — 8,598 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 9 | O'Leary MargaretChief Commercial Officer | Tax withholding | F | $5,132 178 sh | Sep 1, 2026 traded Aug 30, 2026 |
| 8 | Sousa Mauad BrunoDirector | Derivative conversion | C | $858K 10.4K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 8 | Arora TarunChief Accounting Officer | Open-market sale · 10b5-1 plan | SELL | $318K 4,568 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 8 | Zuiker Alicia BrookeEVP, CHRO | Tax withholding | F | $85K 987 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 8 | Chambers TiffaniEVP, Chief Operations Officer | Tax withholding | F | $144K 1,686 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 8 | Cantwell Wayne CDirector | Gift | G | — 5,000 sh | Sep 1, 2026 traded Sep 1, 2026 |
| 7 | Pisano PauloCHIEF HUMAN RESOURCES OFFICER | Open-market sale · 10b5-1 plan | SELL | $610K 3,000 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 7 | Cieri MichaelChief Product Officer | Option exercise · 10b5-1 plan | M | — 12.9K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 7 | Cieri MichaelChief Product Officer | Option exercise · 10b5-1 plan | M | — 6,531 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 7 | Jain RohiniChief Financial Officer | Option exercise · 10b5-1 plan | M | — 11.8K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 6 | Agarwal DeveshChief Operating Officer | Option exercise | M | — 5,218 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 6 | Ragsdale BruceChief Operating Officer | Open-market sale · 10b5-1 plan | SELL | $11K 200 sh | Sep 1, 2026 traded Sep 1, 2026 |
| 6 | Pieper StevenSee Remarks | Open-market sale · 10b5-1 plan | SELL | $43K 5,000 sh | Sep 1, 2026 traded Sep 1, 2026 |
| 6 | Krupka Devin MController, PAO | Option exercise | M | — 1,518 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 6 | Ross KadeChief Information Officer | Option exercise | M | — 3,392 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 6 | Agarwal DeveshChief Operating Officer | Option exercise | M | — 3,927 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 6 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $245K 1,200 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 6 | Agarwal DeveshChief Operating Officer | Option exercise | M | — 5,218 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 6 | Wittmann MichaelChief Operating Officer | Option exercise | M | — 6,250 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 5 | Xu Cong ClaireEVP, Clinical Development | Option exercise | M | — 9,382 sh | Sep 1, 2026 traded Aug 30, 2026 |
| 5 | Truong KristinaChief Accounting Officer | Grant or award | A | — 12.5K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | McClymont DonaldDirector, Chief Executive Officer | Option exercise | M | — 90.8K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | Bottorff RebeccaDirector, Chief People Officer | Option exercise | M | — 1,487 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | Truong KristinaChief Accounting Officer | Tax withholding | F | $22K 6,626 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | Bottorff RebeccaDirector, Chief People Officer | Option exercise | M | — 4,121 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | Renner AlexandraChief Product Officer | Option exercise | M | — 4,173 sh | Sep 1, 2026 traded Aug 31, 2026 |
| 5 | McClymont DonaldDirector, Chief Executive Officer | Grant or award | A | — 90.8K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | Sousa Mauad BrunoDirector | Derivative conversion | C | $85K 1,000 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | Sousa Mauad BrunoDirector | Derivative conversion | C | $210K 2,497 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 5 | Shellberg Jeffrey D.Director | Option exercise | M | — 16.1K sh | Sep 1, 2026 traded Aug 31, 2026 |
| 4 | Britt Christopher RDirector, Chief Executive Officer | Derivative conversion · 10b5-1 plan | C | — 88.6K sh | Sep 1, 2026 traded Aug 28, 2026 |
| 3 | Williams Jennifer A.SVP, Chief Accounting Officer | Tax withholding · 10b5-1 plan | F | $38K 446 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 3 | Cieri MichaelChief Product Officer | Option exercise · 10b5-1 plan | M | — 6,531 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 3 | Mulligan BrendanGeneral Counsel and Secretary | Open-market sale · 10b5-1 plan | SELL | $3,089 100 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 3 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $14K 679 sh | Sep 1, 2026 traded Aug 28, 2026 |
| 2 | Agarwal DeveshChief Operating Officer | Option exercise | M | — 3,927 sh | Sep 1, 2026 traded Aug 28, 2026 |